Register information Protection certificate

DE file number : 12 2015 000 042.8 (Status: pending/in force, Query started: May 7, 2025)

Please note: This English version is a non-binding translation of the German register excerpt. Only the German version of the register excerpt is legally binding.

Master data
INIDCriterionFieldContent
Type of IP rightSARTProtection certificate
StatusSTPending/in force
21DE file number DAKZ12 2015 000 042.8
UseVZMedicinal products
95Product nameTIEZParitaprevir
54Title of basic patentTIGZMAKROCYCLISCHE HEPATITIS-C-SERINPROTEASE-INHIBITOREN
51IPC main classICM
(ICMV)		 A61K 38/00 (2006.01)
51IPC secondary class(es)ICS
(ICSV)		 A61K 38/12 (2006.01), C07D 487/04 (2006.01)
94Start of term of protectionLBSep 11, 2029
94End of term of protectionLEJan 19, 2030
22DE application dateDATMay 21, 2015
Date of publication of application for a certificateOTAug 20, 2015
Date of publication of grant of certificatePETJul 25, 2019
71/73Applicant/ownerINHAbbVie Ireland Unlimited Company, Hamilton, BM; Enanta Pharmaceuticals, Inc., Watertown, Mass., US
74RepresentativeVTRSCHIEBER - FARAGO Patentanwälte, 80538 München, DE
Address for service SCHIEBER - FARAGO Patentanwälte, 80538 München, DE
Due dateFT
FG		Sep 30, 2029
Annual fee for the 21st year Patent fees
Patent division in charge 44
68DE file number of basic patentGAKZ60 2009 022 294.5
68EP file number of basic patentGEAKZ09 81 3360.6
43Date of first publicationEVTAug 20, 2015
92
92
92
Domestic authorisationGIS
GIN
GIT
Europäische Kommission
EU/1/14/982
2015-01-15
93
93
93
93
EU authorisationGES
GEC
GEN
GET
Europäische Kommission
EU
EU/1/14/982
2015-01-15
Date of the first transfer into DPMAregisterEREGTAug 20, 2015
Date of the (most recent) update in DPMAregisterREGTAug 5, 2024
(Show all update days)(Hide all update days)
  • Aug 5, 2024
    • St.36: changed (technical change)
  • Nov 12, 2022; Jun 25, 2022; Jan 25, 2022; Sep 17, 2019; Jul 16, 2019; Jun 15, 2019; Apr 11, 2019; Mar 27, 2019; Jun 6, 2018; Mar 23, 2018; Jan 23, 2018; Sep 7, 2017; Oct 27, 2015
    • Historical data not available for this/these date(s)
  • Aug 20, 2015
    • Date of the first transfer into DPMAregister
Procedural data
No.Kind of procedureLegal statusDate of legal/procedural statusPublication dateAlle Details anzeigen
1 New applicant/owner details New applicant/owner details Jul 13, 2015  Details anzeigen
2 Supplementary protection certificate procedure Application for supplementary protection certificate effectively filed Jul 15, 2015 Aug 20, 2015 Details anzeigen
3 New applicant/owner details New applicant/owner details Sep 6, 2017  Details anzeigen
4 New representative details New representative details Sep 6, 2017  Details anzeigen
5 Supplementary protection certificate procedure Decision to grant supplementary protection certificate by Patent Division Apr 10, 2019  Details anzeigen
6 Supplementary protection certificate procedure Supplementary protection certificate granted May 17, 2019 Jul 25, 2019 Details anzeigen
View procedures New applicant/owner details (No.: 1)
INIDCriterionFieldContent Close details
Type of procedureVARTNew applicant/owner details
Legal/procedural statusVSTNew applicant/owner details
Date of legal/procedural statusVSTTJul 13, 2015
71/73Applicant/ownerINHAbbVie Bahamas Ltd. - Sassoon House, Nassau, New Providence, BS; Enanta Pharmaceuticals, Inc., 02472 Watertown, Mass., US
71/73Previous applicant/ownerINHFAnmelderangaben unklar / unvollständig, 80297 München, DE
View procedures Supplementary protection certificate procedure (No.: 2)
INIDCriterionFieldContent Close details
Type of procedureVARTProtection certificate procedure
Legal/procedural statusVSTApplication for supplementary protection certificate effectively filed
Date of legal/procedural statusVSTTJul 15, 2015
Issue numberHN34
YearPJ2015
Publication dateVTAug 20, 2015
Type of publicationPARTBibliographic data
PartHTPart 7
68DE file number of basic patentGAKZ60 2009 022 294.5
68EP file number of basic patentGEAKZ09 81 3360.6
View procedures New applicant/owner details (No.: 3)
INIDCriterionFieldContent Close details
Type of procedureVARTNew applicant/owner details
Legal/procedural statusVSTNew applicant/owner details
Date of legal/procedural statusVSTTSep 6, 2017
71/73Applicant/ownerINHAbbVie Ireland Unlimited Company, Hamilton, BM; Enanta Pharmaceuticals, Inc., Watertown, Mass., US
71/73Previous applicant/ownerINHFAbbVie Bahamas Ltd. - Sassoon House, Nassau, New Providence, BS, Enanta Pharmaceuticals, Inc., 02472 Watertown, Mass., US
View procedures New representative details (No.: 4)
INIDCriterionFieldContent Close details
Type of procedureVARTNew representative details
Legal/procedural statusVSTNew representative details
Date of legal/procedural statusVSTTSep 6, 2017
74RepresentativeVTRSCHIEBER - FARAGO Patentanwälte, 80538 München, DE
74Previous representativeVTRFFarago-Schauer, Peter, Dipl.-Ing. Univ., 80538 München, DE
Date of update of the procedureREGTJun 25, 2022
View procedures Supplementary protection certificate procedure (No.: 5)
INIDCriterionFieldContent Close details
Type of procedureVARTProtection certificate procedure
Legal/procedural statusVSTDecision to grant supplementary protection certificate by Patent Division
Date of legal/procedural statusVSTTApr 10, 2019
View procedures Supplementary protection certificate procedure (No.: 6)
INIDCriterionFieldContent Close details
Type of procedureVARTProtection certificate procedure
Legal/procedural statusVSTSupplementary protection certificate granted
Date of legal/procedural statusVSTTMay 17, 2019
Issue numberHN30
YearPJ2019
Publication dateVTJul 25, 2019
Type of publicationPARTBibliographic data
PartHTPart 7